Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016674508> ?p ?o ?g. }
- W3016674508 endingPage "1398" @default.
- W3016674508 startingPage "1388" @default.
- W3016674508 abstract "Phenylalanine derivatives, which target tumors especially through L-type amino acid transporter-1 (LAT1), have elicited considerable attention. In this study, we evaluated the treatment effect of phenylalanine labeled with the alpha emitter astatine (211At-PA) in tumor bearing mice. The C6 glioma, U-87MG, and GL261 cell lines were subjected to a cellular 211At-PA uptake analysis that included an evaluation of the uptake inhibition by the system L amino acid transporter inhibitor 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH). BCH significantly inhibited para-211At-PA uptake in C6 glioma (12.2 ± 0.8%), U-87MG (27.6 ± 1.1%), and GL261 (12.6 ± 2.0%) cells compared to baseline, suggesting an uptake contribution by system L amino acid transporters. Subsequently, xenograft and allograft models were prepared by subcutaneously injecting C6 glioma (n = 12) or GL-261 cells (n = 12), respectively. C6 glioma mice received three 211At-PA doses (0.1, 0.5, or 1 MBq, n = 3/dose), while GL261 mice received one high dose (1 MBq, n = 7). 211At-PA exhibited a tumor growth suppression effect in C6 glioma models in a dose-dependent manner as well as in GL-261 models. This phenylalanine derivative labeled with astatine may be applicable as an alpha therapy that specifically targets system L amino acid transporters." @default.
- W3016674508 created "2020-04-24" @default.
- W3016674508 creator A5005266198 @default.
- W3016674508 creator A5017110727 @default.
- W3016674508 creator A5020818857 @default.
- W3016674508 creator A5021151911 @default.
- W3016674508 creator A5030229988 @default.
- W3016674508 creator A5032338769 @default.
- W3016674508 creator A5033775542 @default.
- W3016674508 creator A5034622699 @default.
- W3016674508 creator A5053649418 @default.
- W3016674508 creator A5055631674 @default.
- W3016674508 creator A5080909064 @default.
- W3016674508 creator A5082627299 @default.
- W3016674508 date "2020-04-14" @default.
- W3016674508 modified "2023-10-13" @default.
- W3016674508 title "Targeted alpha therapy using astatine (211At)-labeled phenylalanine: A preclinical study in glioma bearing mice" @default.
- W3016674508 cites W1541891758 @default.
- W3016674508 cites W1599998193 @default.
- W3016674508 cites W1978777024 @default.
- W3016674508 cites W1988207937 @default.
- W3016674508 cites W1991054305 @default.
- W3016674508 cites W2036631945 @default.
- W3016674508 cites W2040329518 @default.
- W3016674508 cites W2052470179 @default.
- W3016674508 cites W2059685528 @default.
- W3016674508 cites W2073297072 @default.
- W3016674508 cites W2094726440 @default.
- W3016674508 cites W2101498866 @default.
- W3016674508 cites W2158681922 @default.
- W3016674508 cites W2165871546 @default.
- W3016674508 cites W2170497549 @default.
- W3016674508 cites W2208974124 @default.
- W3016674508 cites W2236050649 @default.
- W3016674508 cites W2250593255 @default.
- W3016674508 cites W2508747657 @default.
- W3016674508 cites W2527876071 @default.
- W3016674508 cites W2598665375 @default.
- W3016674508 cites W2617800289 @default.
- W3016674508 cites W2760334977 @default.
- W3016674508 cites W2794188675 @default.
- W3016674508 cites W2804630210 @default.
- W3016674508 cites W286430759 @default.
- W3016674508 cites W2891802261 @default.
- W3016674508 cites W2902054414 @default.
- W3016674508 cites W2915242013 @default.
- W3016674508 cites W2919455080 @default.
- W3016674508 cites W2921986565 @default.
- W3016674508 cites W2967856517 @default.
- W3016674508 doi "https://doi.org/10.18632/oncotarget.27552" @default.
- W3016674508 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7170498" @default.
- W3016674508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32341757" @default.
- W3016674508 hasPublicationYear "2020" @default.
- W3016674508 type Work @default.
- W3016674508 sameAs 3016674508 @default.
- W3016674508 citedByCount "28" @default.
- W3016674508 countsByYear W30166745082020 @default.
- W3016674508 countsByYear W30166745082021 @default.
- W3016674508 countsByYear W30166745082022 @default.
- W3016674508 countsByYear W30166745082023 @default.
- W3016674508 crossrefType "journal-article" @default.
- W3016674508 hasAuthorship W3016674508A5005266198 @default.
- W3016674508 hasAuthorship W3016674508A5017110727 @default.
- W3016674508 hasAuthorship W3016674508A5020818857 @default.
- W3016674508 hasAuthorship W3016674508A5021151911 @default.
- W3016674508 hasAuthorship W3016674508A5030229988 @default.
- W3016674508 hasAuthorship W3016674508A5032338769 @default.
- W3016674508 hasAuthorship W3016674508A5033775542 @default.
- W3016674508 hasAuthorship W3016674508A5034622699 @default.
- W3016674508 hasAuthorship W3016674508A5053649418 @default.
- W3016674508 hasAuthorship W3016674508A5055631674 @default.
- W3016674508 hasAuthorship W3016674508A5080909064 @default.
- W3016674508 hasAuthorship W3016674508A5082627299 @default.
- W3016674508 hasBestOaLocation W30166745081 @default.
- W3016674508 hasConcept C104317684 @default.
- W3016674508 hasConcept C149011108 @default.
- W3016674508 hasConcept C185592680 @default.
- W3016674508 hasConcept C2777431362 @default.
- W3016674508 hasConcept C2778227246 @default.
- W3016674508 hasConcept C2781313199 @default.
- W3016674508 hasConcept C502942594 @default.
- W3016674508 hasConcept C515207424 @default.
- W3016674508 hasConcept C55493867 @default.
- W3016674508 hasConcept C71924100 @default.
- W3016674508 hasConcept C98274493 @default.
- W3016674508 hasConceptScore W3016674508C104317684 @default.
- W3016674508 hasConceptScore W3016674508C149011108 @default.
- W3016674508 hasConceptScore W3016674508C185592680 @default.
- W3016674508 hasConceptScore W3016674508C2777431362 @default.
- W3016674508 hasConceptScore W3016674508C2778227246 @default.
- W3016674508 hasConceptScore W3016674508C2781313199 @default.
- W3016674508 hasConceptScore W3016674508C502942594 @default.
- W3016674508 hasConceptScore W3016674508C515207424 @default.
- W3016674508 hasConceptScore W3016674508C55493867 @default.
- W3016674508 hasConceptScore W3016674508C71924100 @default.
- W3016674508 hasConceptScore W3016674508C98274493 @default.
- W3016674508 hasIssue "15" @default.
- W3016674508 hasLocation W30166745081 @default.